KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nu Skin Enterprises (NUS) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Nu Skin Enterprises (NUS) over the last 17 years, with Q1 2025 value amounting to $176.2 million.

  • Nu Skin Enterprises' Other Operating Expenses changed N/A to $176.2 million in Q1 2025 from the same period last year, while for Sep 2025 it was $387.5 million, marking a year-over-year increase of 10250.98%. This contributed to the annual value of $854.4 million for FY2024, which is 1210.3% up from last year.
  • Per Nu Skin Enterprises' latest filing, its Other Operating Expenses stood at $176.2 million for Q1 2025.
  • Over the past 5 years, Nu Skin Enterprises' Other Operating Expenses peaked at $280.6 million during Q2 2021, and registered a low of $176.2 million during Q1 2025.
  • Moreover, its 5-year median value for Other Operating Expenses was $213.9 million (2022), whereas its average is $221.4 million.
  • As far as peak fluctuations go, Nu Skin Enterprises' Other Operating Expenses surged by 3393.63% in 2021, and later tumbled by 2363.96% in 2022.
  • Nu Skin Enterprises' Other Operating Expenses (Quarter) stood at $263.3 million in 2021, then fell by 23.64% to $201.0 million in 2022, then dropped by 4.83% to $191.3 million in 2023, then increased by 10.44% to $211.3 million in 2024, then decreased by 16.63% to $176.2 million in 2025.
  • Its Other Operating Expenses stands at $176.2 million for Q1 2025, versus $211.3 million for Q4 2024 and $191.3 million for Q4 2023.